124
Views
0
CrossRef citations to date
0
Altmetric
Articles

Resveratrol-loaded polycaprolactone scaffolds obtained by rotary jet spinning

, , , , &
Pages 289-301 | Received 22 Dec 2021, Accepted 15 Apr 2022, Published online: 02 May 2022
 

Abstract

The production of scaffolds has proved a solid option in bioengineering aimed at tissue neoformation due to their characteristics that favor cell recruitment and proliferation and may even provide the necessary mechanical characteristics during tissue reestablishment phases. Several combinations have been proposed in the manufacture of biomaterials, such as the association of components that can increase or enhance their action on the host tissue. This work aimed to produce and evaluate in vitro composite scaffolds composed of the polymer polycaprolactone and the polyphenol resveratrol, produced by the rotary jet spinning process, as a bone grafting material, envisioning future uses in tissue engineering. The following samples were produced: polycaprolactone scaffold (control), polycaprolactone scaffolds with resveratrol at 1%, 3%, and 5%. Morphological evaluation under scanning electron microscopy evidenced that the produced scaffolds have fibers with random distribution, diameters, and porosities that can favor cell migration and adhesion. The in vitro analyses showed that the samples have a similar behavior to control in the 24-h period and that the PCL/RESV 5% scaffold provided cell growth over time in the 72-h evaluation since PCL is a polymer with consolidated use in the production of biomaterials and the scaffolds proved promising in carrying phytotherapy medicines.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The statistical analysis data used to support the findings of this study are available from the corresponding author upon request.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.